BioLife Sciences Inc.
BLFE
Other OTC0.00
USD
- -
- -
CIK
0001929281
ISIN
US09076L1035
CUSIP
09076L103
Return %
Stock
S&P500
1Y
9,900.00
26.57
3Y
-50.00
76.60
5Y
-99.97
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Justin De Four
- Full Time Employees
- 3
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 5285 Bradco Blvd Henderson ON Canada L4W 2A6
- IPO Date
- Apr 25, 2005
- CIK
- 0001929281
- Website
- biolifesciences.com
- Similar Companies
- Business
- BioLife Sciences Inc. develops, licenses, and commercializes innovative and disruptive technologies primarily for the healthcare, beauty, and food and beverage industries. Its product portfolio includes antimicrobial copper air filters, copper-infused textiles, and natural health products with a focus on orthomolecular and nutraceutical segments. The company also offers novel cannabinoid consumer products based on industrial hemp, including tinctures, throat syrups, teas, energy shots, and pet wellness items. BioLife commercializes antimicrobial fabrics developed through its proprietary MFusion process, featuring partnerships with firms such as Canadian-based Work In Motion for copper-infused bamboo gardening gloves. Recent strategic developments include the acquisition of Health Box LLC, the launch of a dedicated life sciences division, and initiatives to expand its presence in the cannabinoid and hemp-derived products market. The company aims to become a fully reporting SEC filer and up-list to the OTCQB market, supported by engagements with auditing and consulting firms and enhanced corporate communications partnerships. Headquartered in Henderson, Nevada, and founded prior to major product expansions in 2022–2023, BioLife operates as a commercialization accelerator and licensor, focusing on growth in the healthcare, beauty, and food and beverage sectors globally through innovative product commercialization and strategic collaborations.
BioLife Sciences, Inc. (OTC:PK BLFE) (BioLife or the Company) is Pleased to Announce the Release of the Prototype of the Company's Copper-Infused Microfiber Towels for Q2 of the Fiscal Year
BioLife Sciences Inc. (OTC:PK BLFE) is Pleased to Announce Its Q1 2023 Slated Release of Its Copper-Infused Fabric Pot Prototype